ReachMD

Episodes 1-15 of 39

• • 

    

    Brendan J. Canning, PhD

    Peer

  • 

    

    Peter Dicpinigaitis, MD

    Peer

  3

  

  RestartResume

  Opening a New Chapter on the Diagnosis and Management of Unexplained Chronic Cough

  Opening a New Chapter on the Diagnosis and Management of Unexplained Chronic Cough

  0.25 credits

• • 

    

    Peter Dicpinigaitis, MD

    Peer

  • 

    

    Brendan J. Canning, PhD

    Peer

  5

  

  RestartResume

  Unexplained Chronic Cough—Not Just a Disease Symptom, but a Condition unto Itself

  Unexplained Chronic Cough—Not Just a Disease Symptom, but a Condition unto Itself

  0.25 credits

• • 

    

    Richard Channick, MD

    Peer

  • 

    

    Vallerie Mclaughlin, MD

    Peer

  5

  

  RestartResume

  Pulmonary Arterial Hypertension A Deeper Dive

  Pulmonary Arterial Hypertension A Deeper Dive

  1.00 credits

• • 

    

    Zulma Yunt, MD

    Peer

  • 

    

    Amy L. Olson, MD, MSPH

    Peer

  • 

    

    Virginia D. Steen, MD

    Peer

  4

  

  RestartResume

  SSc-ILD: The Importance of Early Diagnosis, Patient Centered Communication and Evidence Based Treatment

  SSc-ILD: The Importance of Early Diagnosis, Patient Centered Communication and Evidence Based Treatment

  1.00 credits

• • 

    

    Kevin Brown, MD

    Peer

  • 

    

    Kevin R. Flaherty, MD

    Peer

  • 

    

    Rebecca C. Keith, MD

    Peer

  6

  

  RestartResume

  Emerging Treatments: Diagnosis and Treatment of Chronic Fibrosing ILD with a Progressive Lung Disease Phenotype

  Emerging Treatments: Diagnosis and Treatment of Chronic Fibrosing ILD with a Progressive Lung Disease Phenotype

  1.00 credits

• • 

    

    Karen Reckamp, MS, MD

    Peer

  • 

    

    Heather Wakelee, MD

    Peer

  5

  

  RestartResume

  Optimizing Patient Outcomes in Advanced NSCLC in a Rapidly Evolving Treatment Era

  Optimizing Patient Outcomes in Advanced NSCLC in a Rapidly Evolving Treatment Era

  1.00 credits

• • 

    

    Karen Reckamp, MS, MD

    Peer

  • 

    

    Heather Wakelee, MD

    Peer

  7

  

  RestartResume

  Optimizing Patient Outcomes in Advanced NSCLC in a Rapidly Evolving Treatment Era: A Video-based Patient Case Series

  Optimizing Patient Outcomes in Advanced NSCLC in a Rapidly Evolving Treatment Era: A Video-based Patient Case Series

  0.50 credits

• • 

    

    Charles Daley, MD

    Peer

  • 

    

    Shannon H. Kasperbauer, MD

    Peer

  5

  

  RestartResume

  Improving Outcomes in NTM-LD: Strategies for Diagnosis, Individualized Treatment Plans and Patient Adherence

  Improving Outcomes in NTM-LD: Strategies for Diagnosis, Individualized Treatment Plans and Patient Adherence

  1.00 credits

• • 

    

    William Mencia, MD, FACEHP, CHCP

    Peer

  • 

    

    Gregory S. Sawicki, MD, MPH

    Peer

  3

  

  RestartResume

  Cystic Fibrosis: Overcoming Barriers to Nutrition Adherence

  Cystic Fibrosis: Overcoming Barriers to Nutrition Adherence

  0.25 credits

• • 

    

    Sandra G. Adams, MD, MS, FCCP

    Peer

  • 

    

    Sumita B. Khatri, MD, MS, FCCP

    Peer

  1

  

  RestartResume

  Uncovering Severe Asthma Mimickers & Drivers

  Uncovering Severe Asthma Mimickers & Drivers

  0.25 credits

• • 

    

    Sandra G. Adams, MD, MS, FCCP

    Peer

  • 

    

    Mario Castro, MD, MPH

    Peer

  4

  

  RestartResume

  The Role of Targeted Therapy in Severe Asthma with Type 2 Inflammation

  The Role of Targeted Therapy in Severe Asthma with Type 2 Inflammation

  0.25 credits

• • 

    

    Sandra G. Adams, MD, MS, FCCP

    Peer

  • 

    

    Anju T Peters, MD, MSCI, FAAAAI

    Peer

  4

  

  RestartResume

  A Practical Approach to Severe Asthma Therapies

  A Practical Approach to Severe Asthma Therapies

  0.25 credits

• • 

    

    Barbara Yawn, MD, MSc, FAAFP

    Peer

  • 

    

    John J. Russell, MD

    Peer

  4

  

  RestartResume

  Improving Severe Asthma Outcomes: A New Era in Identification and Management

  Improving Severe Asthma Outcomes: A New Era in Identification and Management

  0.50 credits

• • 

    

    Sandhya Khurana, MD, FCCP

    Peer

  • 

    

    Fernando Holguin, MD, MPH

    Peer

  1

  

  RestartResume

  Treatment Options in Non-Type 2 Asthma

  Treatment Options in Non-Type 2 Asthma

  0.25 credits

• • 

    

    Sandhya Khurana, MD, FCCP

    Peer

  • 

    

    Monica Kraft, MD, FCCP

    Peer

  0

  

  RestartResume

  Understanding Asthma Immunology, Phenotypes, & Biomarkers

  Understanding Asthma Immunology, Phenotypes, & Biomarkers

  0.25 credits

• 1
• 2
• 3
• Next